Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Elyseisk R&S AB
AB
Active
Org 5592410343
Kantorsgatan 3 B
Medical specialists activities · NACE 8622
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 147K
-40% vs 2024
EBITDA margin
60.2%
-51% vs 2024
Equity ratio
146.4%
Financial strength
Net profit 2025
SEK 70K
-51% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 147K
-40%
EBITDA
SEK 89K
-51%
Net profit
SEK 70K
-51%
Total assets
SEK 204K
-57%
Equity
SEK 299K
-30%
Employees
0
—
Company information
Legal name
Elyseisk R&S AB
Org number
5592410343
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom vården. Fakturering direkt till bolaget.
Contact
Address
Kantorsgatan 3 B
Email
ramin_sahar@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
269
525
374
246
147
Staff expenses
—
—
−4
−37
−5
EBITDA
213
484
339
179
89
Depreciation & amort.
−0
−0
—
—
—
EBIT
213
484
339
179
89
Net financials
—
—
0
−0
−1
Profit before tax
213
484
339
179
88
Tax
−46
−100
−63
−37
−18
Net profit
167
384
276
142
70
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
270
631
680
476
204
Equity
192
411
488
430
299
Long-term debt
0
0
—
—
—
Short-term debt
78
219
193
46
−95
Total debt
78
219
193
46
−95
Financial ratios
5-year trend
EBITDA margin
60.2%
This company
15.8%
Market median
+281% vs market
2021
2025
Equity ratio
146.4%
This company
38.2%
Market median
+283% vs market
2021
2025
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
2021
2025
Net profit margin
47.3%
This company
8.1%
Market median
+484% vs market
2021
2025
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
2021
2025
Debt / equity
-0.32×
This company
0.62×
Market median
+152% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-01-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
RS
Ramin Sahar
Board of Directors
2022
SK
Samira Khadijah Sahar
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Elyseisk R&S AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ramin Sahar
Board of Directors
0 companies
Samira Khadijah Sahar
Deputy Board Member
0 companies